Evidence map›Paper›PMID 42051389›Full record

ArticleJournal of the West African College of Surgeons

Association of Chlamydia Trachomatis Sero-Positivity with Male Infertility in the Niger-Delta Region of Nigeria: A Case-Control Study.

Newton Asaboro, Lawrence Omo-Aghoja, Ayotunde Adeyinka

Abstract read
In one paragraph

Article in Journal of the West African College of Surgeons. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Newton AsaboroDepartment of Obstetrics and Gynecology, Delta State University Teaching Hospital, Oghara, Delta, Nigeria.
Lawrence Omo-AghojaDepartment of Obstetrics and Gynecology, Delta State University Teaching Hospital, Oghara, Delta, Nigeria.
Ayotunde AdeyinkaDepartment of Obstetrics and Gynecology, Asaba Specialist Hospital, Asaba, Delta, Nigeria.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The role of chlamydia infection in the causation of male infertility has not been conclusively evaluated, especially in the developing countries of sub-Saharan Africa that are worst affected by infertility. Understanding the relationship between the two will guide the deployment of preventive efforts and investigative approaches more scientifically. Patients Materials and Methods: This was a case-control study of two groups of males: 68 male partners of infertile couples with abnormal semen parameters attending a fertility clinic and 68 age-matched male partners (with normal semen parameters) of females attending the family planning clinic as controls at two tertiary hospitals in Delta State. The prevalence of chlamydial sero-positivity, the socio-demographic characteristics, sexual and reproductive characteristics, and chlamydial serology of all the participants were determined and compared using appropriate statistical tools. Results: Most (41.2%) of the participants were in the 35-39 years age category; they were all married and were mostly (66.2%) skilled workers. The overall prevalence of chlamydia sero-positivity in this study was 11.8%. The prevalence of chlamydia sero-positivity was significantly higher amongst the study group (19.1%) compared with controls (4.4%) ( Conclusion: There was a significant association between chlamydia trachomatis infection and abnormal semen parameters. There were no identified independent predictors of chlamydia trachomatis sero-positivity.

Indexed as

Chlamydial trachomatis sero-positivitymale infertilityoligospermiateratozoospermia

Identifiers

PMID42051389
PMCPMC13120801

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.